BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
Salar Farokhi Boroujeni(University of Ottawa), Barbara C. Vanderhyden(University of Ottawa)
Cited by 22
Related Papers
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
|Oncogene|2018|88
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
|Communications Biology|2023|29
PAX2 induces vascular‑like structures in normal ovarian cells and ovarian cancer
|Experimental and Therapeutic Medicine|2022|8